Human genome wide association studies (GWAS) have shown between 30 and 50% of Crohn's disease patients have NOD2 polymorphisms, suggesting NOD2 polymorphisms are a risk factor for disease, but alone, not sufficient or necessary for disease (32, 36). This evidence concerns the gene NOD2 and Crohn disease.